- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Iterum Therapeutics PLC (ITRMF)
Iterum Therapeutics PLC stock price live, this page displays OTC ITRMF stock exchange data. View the ITRMF premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Iterum Therapeutics PLC real time stock price chart below.
What Is the Iterum Therapeutics PLC Stock Price Today?
The Iterum Therapeutics PLC stock price today is 0.022.
What Is the Stock Symbol for Iterum Therapeutics PLC?
The stock ticker symbol for Iterum Therapeutics PLC is ITRMF.
Is ITRMF the Same as $ITRMF?
$ITRMF is a common way to refer to the Iterum Therapeutics PLC ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Iterum Therapeutics PLC Trade On?
Iterum Therapeutics PLC is listed and trades on the OTC Markets stock exchange.
Is Iterum Therapeutics PLC a Good Stock to Buy?
Determining whether Iterum Therapeutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Iterum Therapeutics PLC share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ITRMF quote. (ISIN: IE000TTOOBX0)
What Is the Iterum Therapeutics PLC Stock Price Today?
The Iterum Therapeutics PLC stock price today is 0.022.
What Is the Stock Symbol for Iterum Therapeutics PLC?
The stock ticker symbol for Iterum Therapeutics PLC is ITRMF.
Is ITRMF the Same as $ITRMF?
$ITRMF is a common way to refer to the Iterum Therapeutics PLC ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Iterum Therapeutics PLC Trade On?
Iterum Therapeutics PLC is listed and trades on the OTC Markets stock exchange.
Is Iterum Therapeutics PLC a Good Stock to Buy?
Determining whether Iterum Therapeutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Iterum Therapeutics PLC share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ITRMF quote. (ISIN: IE000TTOOBX0)
0.022
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.019
0.022
52 wk Range
0.007
1.420
ITRMF is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0190.022
52 wk Range
0.0071.420
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ITRMF Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Iterum Therapeutics plc is in reorganization.
Iterum Therapeutics PLC Earnings Call Summary for Q3/2025
- Iterum Therapeutics missed Q3 2025 EPS with a loss of $0.16 vs. expected $0.11, causing shares to drop 13.45% in pre-market trading
- Despite launching Orlyvah with 280+ prescriptions since August, net loss widened to $9 million from $6.1 million YoY as operating expenses rose to $8.1 million
- The company reported $400,000 in initial product revenue and plans to raise additional capital to support commercialization efforts
- Management projects 2026 net product revenues between $5-15 million with operating expenses of $25-30 million
- CEO Corey Fishman highlighted physician adoption of Orlyvah for urinary tract infections, though market acceptance remains uncertain
Last Updated: 11/14/2025, 09:49 AM
Read Full TranscriptCompare ITRMF to Peers and Sector
Metrics to compare | ITRMF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipITRMFPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −7.4x | −0.5x | |
PEG Ratio | 0.00 | 0.02 | 0.00 | |
Price / Book | −0.2x | 1.9x | 2.6x | |
Price / LTM Sales | 3.0x | 1.9x | 3.2x | |
Upside (Analyst Target) | - | 154.0% | 47.6% | |
Fair Value Upside | Unlock | 4.1% | 6.1% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.000
Earnings
Latest Release
Mar 12, 2026
EPS / Forecast
-0.20 / -0.15
Revenue / Forecast
410K / 505K
People Also Watch
FAQ
What Is the Iterum Therapeutics (ITRMF) Stock Price Today?
The Iterum Therapeutics stock price today is 0.022 USD.
What Stock Exchange Does Iterum Therapeutics Trade On?
Iterum Therapeutics is listed and trades on the OTC Markets.
What Is the Stock Symbol for Iterum Therapeutics?
The stock symbol for Iterum Therapeutics is "ITRMF."
What Is the Iterum Therapeutics Market Cap?
As of today, Iterum Therapeutics market cap is 1.160M USD.
What Is Iterum Therapeutics's Earnings Per Share (TTM)?
The Iterum Therapeutics EPS (TTM) is -0.737.
When Is the Next Iterum Therapeutics Earnings Date?
Iterum Therapeutics will release its next earnings report on May 20, 2026.
From a Technical Analysis Perspective, Is ITRMF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Iterum Therapeutics Stock Split?
Iterum Therapeutics has split 1 times.
How Many Employees Does Iterum Therapeutics Have?
Iterum Therapeutics has 9 employees.
What is the current trading status of Iterum Therapeutics (ITRMF)?
As of Apr 15, 2026, Iterum Therapeutics (ITRMF) is trading at a price of 0.022 USD, with a previous close of 0.022 USD. The stock has fluctuated within a day range of 0.019 USD to 0.022 USD, while its 52-week range spans from 0.007 USD to 1.420 USD.
What Is the ITRMF After Hours Price?
ITRMF's last after hours stock price is 0.040 USD, the stock has decreased by 0.006, or 18.690%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.